PAK1 and esophageal squamous cell carcinoma: In this study, we also demonstrated that targeting PAK1 by shRNA or pharmacology inhibitor IPA-3 could significantly suppress ESCC cell growth, migration, invasion and metastasis in vitro and in vivo.